Drug for fungal infections in lung transplant recipients increases risk for cancer, death

Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail